An interventional study of pinaverium bromide and Vitamin C in Bile Duct Diseases, sponsored by Changhai Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-06-12.
Sponsored by Changhai Hospital · Not applicable, Interventional, and Treatment
Pinaverium bromide can be used to treat symptoms related to irritable bowel syndrome (IBS) and functional disorders of the biliary tract. In this study, pinaverium bromide was compared with Vitamin C for the facilitation of bile duct and pancreatic duct cannulation in patients. The primary outcome was successful deep bile duct cannulation and pancreatic duct canulation. The second outcome was the major papillary orifice,bile juice flow from the papilla, time to achieve deep bile duct cannulation, fluoroscopy time for deep bile duct cannulation,the appearance of the major and minor papillary orifice, pancreatic juice flow from the papilla, time to achieve deep pancreatic duct cannulation, and fluoroscopy time for deep pancreatic duct cannulation in the pinaverium bromide group versus Vitamin C group.
56 studies on the registry are indexed under Bile Duct Diseases; 16 are open to participants now.
This study's planned enrollment of 200 is above the median of 93 across 34 interventional studies indexed under Bile Duct Diseases.
Browse Bile Duct Diseases studies →Changhai Hospital is the lead sponsor of 342 studies on the registry; 133 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
take 50 mg pinaverium bromide three times a day 1 days before and then 100 mg 1 hour before the examination orally
Dietary Supplement: pinaverium bromide
take 50 mg Vitamin C three times a day 1 days before and then 100 mg 1 hour before the examination orally
Dietary Supplement: Vitamin C
cannulation time for deep bile duct cannulation and pancreatic duct cannulation
Time frame: 2 days
bile juice flow from the major papilla and pancreatic juice flow from the major papilla
Time frame: 2 days
appearance of the major papillary orifice
Time frame: 2 days
This study is status unknown, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Changhai Hospital